Legacy Trust Acquires 356 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Legacy Trust boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,142 shares of the medical equipment provider’s stock after acquiring an additional 356 shares during the period. Intuitive Surgical accounts for about 1.5% of Legacy Trust’s investment portfolio, making the stock its 28th largest holding. Legacy Trust’s holdings in Intuitive Surgical were worth $6,338,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of ISRG. Bennett Selby Investments LP raised its holdings in Intuitive Surgical by 3.9% in the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after buying an additional 17 shares during the last quarter. LVW Advisors LLC increased its position in shares of Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after acquiring an additional 19 shares in the last quarter. Wesbanco Bank Inc. raised its holdings in Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after acquiring an additional 19 shares during the last quarter. Hazlett Burt & Watson Inc. lifted its position in Intuitive Surgical by 5.8% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock valued at $177,000 after acquiring an additional 20 shares in the last quarter. Finally, Mitchell Mcleod Pugh & Williams Inc. boosted its stake in Intuitive Surgical by 4.1% during the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after purchasing an additional 20 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, insider Jamie Samath sold 22,903 shares of the firm’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,597,425. This trade represents a 72.34 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 28,843 shares of company stock valued at $15,357,560 over the last 90 days. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Down 0.2 %

Shares of NASDAQ:ISRG opened at $572.71 on Thursday. The stock has a 50 day moving average of $548.70 and a 200 day moving average of $507.04. The company has a market cap of $203.99 billion, a PE ratio of 92.08, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Analyst Ratings Changes

Several research analysts have recently weighed in on the company. UBS Group boosted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday. Citigroup boosted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. JPMorgan Chase & Co. raised their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Royal Bank of Canada boosted their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday. Finally, Stifel Nicolaus raised their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.